Summary
Human inherited retinal diseases (IRDs) result from mutations in over 250 different genes, many of them implicated by the Leeds Vision Research Group (eg Panagiotou et al 2017, AJHG 100:960-968; El-Asrag et al 2015, 96:948-54). While these discoveries have greatly increased our understanding of the proteins and pathways underlying these disorders, we know very little about the molecular processes which underlie the huge variation in symptoms and severity seen between individuals. In its most extreme form, some primary mutation carriers have no symptoms while other family members with the same mutation are blind from infancy. Understanding the causes of this variability will allow accurate counselling and molecular testing of IRDs and will facilitate the development of therapies for IRDs and other common complex eye disorder.
It is commonly accepted that this variability in penetrance and disease expression is governed at least in part by secondary genetic factors. This project will aim to identify these genetic modifiers and functionally validate then using in in vitro cellular systems. This project will provide research training in genomics and cell biology including the bioinformatics analysis of whole exome/genome sequencing, cell culture, gene editing, siRNA/shRNA gene knockdown and microscopy.
